Molecular Templates, Inc. Contracts & Agreements

Sub-Sublease, dated May 12, 2024, by and between the Company and TracerDx (Filed With SEC on August 14, 2024)

Description of the Companys securities (Filed With SEC on March 29, 2024)

Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board of Directors of the Company on October 9, 2017, amended as of May 31, 2018 and further amended... (Filed With SEC on March 29, 2024)

Form of Prefunded Warrant to Purchase Common Stock (Filed With SEC on March 28, 2024)

Form of Common Warrant (Filed With SEC on March 28, 2024)

Amended and Restated Securities Purchase Agreement dated March 28, 2024 (Filed With SEC on March 28, 2024)

Molecular Templates, Inc. Clawback Policy (Filed With SEC on November 13, 2023)

Employment Agreement, dated September 26, 2023, by and between the Company and Maurizio Voi, M.D (Filed With SEC on September 28, 2023)

Employment Agreement, dated August 1, 2023, by and between the Company and Gabriela Gruia, M.D (Filed With SEC on August 2, 2023)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on July 13, 2023)

Form of Common Warrant (Filed With SEC on July 13, 2023)

Securities Purchase Agreement dated July 12, 2023 (Filed With SEC on July 13, 2023)

Fourth Amendment to the Lease Agreement, dated October 18, 2022, by and between NW Austin Officer Partners LLC and Molecular Templates, Inc (Filed With SEC on November 10, 2022)

First Amendment to Loan and Security Agreement, dated May 21, 2020, by and among the Company, Molecular Templates OpCo, Inc., and, K2 Health Ventures LLC and Ankura Trust Company,... (Filed With SEC on May 13, 2022)

Amendment No. 1 to Collaboration Agreement, dated December 2, 2021, by and between the Company and Bristol-Myers Squibb Company (Filed With SEC on March 29, 2022)

Executive Employment Agreement by and between Molecular Templates, Inc. and Sean McLennan dated November 4, 2019 (Filed With SEC on August 13, 2021)

First Amendment to Executive Employment Agreement by and between Molecular Templates, Inc. and Sean McLennan effective July 2, 2021 (Filed With SEC on August 13, 2021)

Collaboration Agreement by and between Molecular Templates, Inc. and Bristol-Myers Squibb Company dated February 10, 2021 (Filed With SEC on May 14, 2021)

Underwriting Agreement, dated February 17, 2021, among Molecular Templates, Inc. and BofA Securities, Inc., Cowen and Company, LLC and Evercore Group L.L.C., as representatives of... (Filed With SEC on February 22, 2021)

Sales Agreement, dated August 7, 2020, by and between Molecular Templates, Inc. and Cowen and Company, LLC (Filed With SEC on August 7, 2020)

Loan and Security Agreement, dated May 21, 2020, by and among Molecular Templates, Inc., Molecular Templates OpCo, Inc., and, K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on May 22, 2020)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on December 19, 2019)

Underwriting Agreement, dated November 20, 2019, among Molecular Templates, Inc. and Cowen and Company, LLC, Barclays Capital Inc. and Stifel, Nicolaus & Company, Incorporated, as... (Filed With SEC on November 25, 2019)

First Amendment to the Development Collaboration and Exclusive License Agreement, dated as of July 18, 2019, by and between Molecular Templates, Inc. and Millennium... (Filed With SEC on November 12, 2019)

First Amendment to Sublease, dated as of May 20, 2019, by and between Molecular Templates, Inc. and State Farm Mutual Automobile Insurance Company (Filed With SEC on August 12, 2019)

Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board of Directors of the Company on June 14, 2018 (Filed With SEC on March 29, 2019)

Sublease, dated as of January 23, 2019, by and between Molecular Templates, Inc. and State Farm Mutual Automobile Insurance Company (Filed With SEC on March 29, 2019)

Underwriting Agreement, dated September 20, 2018, among Molecular Templates, Inc. and Cowen and Company, LLC and Evercore Group L.L.C., as representatives of the several... (Filed With SEC on September 24, 2018)

Cancer Research Grant Contract, dated as of November 7, 2012, by and between the Cancer Prevention & Research Institute of Texas and Molecular Templates, Inc (Filed With SEC on June 22, 2018)

Molecular Templates, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 1, 2018)

Form of Warrant issued to Wedbush Securities, dated December 1, 2017 (Filed With SEC on March 30, 2018)

Form of Stock Option Grant Notice and Option Agreement for employees under the 2014 Equity Incentive Plan (Filed With SEC on March 30, 2018)

Form of Stock Option Grant Notice and Option Agreement for non-employee directors under the 2014 Equity Incentive Plan (Filed With SEC on March 30, 2018)

Amended and Restated Executive Employment Agreement, dated November 3, 2017, by and between the Company and Adam D. Cutler (Filed With SEC on March 30, 2018)

Second Amendment to the Lease Agreement, dated October 1, 2016, by and between NW Austin Officer Partners LLC and Molecular Templates OpCo, Inc., dated March 29, 2017 (Filed With SEC on March 30, 2018)

Third Amendment to the Lease Agreement, dated October 1, 2016, by and between NW Austin Officer Partners LLC and Molecular Templates OpCo, Inc., dated June 27, 2017 (Filed With SEC on March 30, 2018)

Molecular Templates Amended and Restated 2009 Stock Plan, as amended through September 19, 2013 (Filed With SEC on March 30, 2018)

Molecular Templates 2009 Stock Plan Form of Option Agreement (Filed With SEC on March 30, 2018)

Credit Agreement and Guaranty, dated as of February 27, 2018, among the Molecular Templates OpCo, Inc., a Delaware corporation, as borrower, Molecular Templates, Inc., a Delaware... (Filed With SEC on March 2, 2018)

Warrant to Purchase Common Stock issued to Perceptive Credit Holdings II, LP (Filed With SEC on March 2, 2018)

Registration Rights Agreement, dated February 27, 2018, by and between Molecular Templates, Inc. and Perceptive Credit Holdings II, LP (Filed With SEC on March 2, 2018)

Multi-License Collaboration and License Agreement, dated June 23, 2017, between Molecular Templates OpCo and Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda... (Filed With SEC on October 17, 2017)

2014 Equity Incentive Plan, as amended (Filed With SEC on October 13, 2017)

Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board of Directors of the Company on October 9, 2017 (Filed With SEC on October 13, 2017)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on August 7, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 7, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 7, 2017)

MOLECULAR TEMPLATES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 7, 2017)

MULTI-TARGET COLLABORATION AND LICENSE AGREEMENT Between MOLECULARTEMPLATES, INC. and MILLENNIUM PHARMACEUTICALS, INC. Portions of this Exhibit,indicated by the mark [***], were... (Filed With SEC on August 7, 2017)

Asset Transfer Agreement By and between Threshold Pharmaceuticals,Inc., A corporation organized and existing under thelaws of the State of Delaware, together with its successors... (Filed With SEC on June 22, 2017)

Form of Equity Commitment Letter by and between Registrant, Molecular Templates, Inc. and Longitude Venture Partners III, L.P., dated as of March 16, 2017 (Filed With SEC on May 15, 2017)

FIRST AMENDMENT TO LEASE (Filed With SEC on May 15, 2017)

SUBLEASE (Filed With SEC on May 15, 2017)

LEASE BETWEEN EVERGREEN SHIPPING AGENCY (AMERICA) CORPORATION LANDLORD AND MOLECULAR TEMPLATES, INC. TENANT DATED:August 11, 2016 INDEX (Filed With SEC on May 15, 2017)

CONFIDENTIAL TREATMENT REQUESTED Research Collaboration and Option Agreement (Filed With SEC on May 15, 2017)

CONFIDENTIAL TREATMENT REQUESTED NON-EXCLUSIVE LICENSE AGREEMENT FOR THE PROVISION OF BIOLOGICAL MATERIALS FOR INTERNAL RESEARCH ONLY BETWEEN THE HENRY M. JACKSONFOUNDATION FOR... (Filed With SEC on May 15, 2017)

Portions of this Exhibit, indicated by the mark [***], were omitted and have been filed separately with the Secretary of theCommission pursuant to the Registrants application... (Filed With SEC on May 15, 2017)

MOLECULAR TEMPLATES, INC. AMENDMENT TO 2009 STOCK PLAN Effective as of September 19, 2013 (Filed With SEC on May 15, 2017)

[Signature page follows] (Filed With SEC on May 15, 2017)

[MERCURY] WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on May 15, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 15, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 15, 2017)

NOTE PURCHASE AGREEMENT (Filed With SEC on May 15, 2017)

MOLECULAR TEMPLATES, INC. 2009 STOCK PLAN STOCKOPTION AGREEMENT (Filed With SEC on May 15, 2017)

MOLECULAR TEMPLATES, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 15, 2017)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2017)

MOLECULAR TEMPLATES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2017)

FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2017)

MOLECULAR TEMPLATES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2017)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among THRESHOLD PHARMACEUTICALS, INC. a Delaware corporation; TROJAN MERGER SUB, INC., and MOLECULAR TEMPLATES, INC. Dated as of... (Filed With SEC on March 17, 2017)

SUPPORT AGREEMENT (Filed With SEC on March 17, 2017)

SUPPORTAGREEMENT (Filed With SEC on March 17, 2017)

Lock-Up Agreement March 16, 2017 (Filed With SEC on March 17, 2017)

TERMINATION AND RETURN OF RIGHTS AGREEMENT (Filed With SEC on May 5, 2016)

FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 5, 2016)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 5, 2016)

THRESHOLD PHARMACEUTICALS, INC. $50,000,000 SALES AGREEMENT (Filed With SEC on November 2, 2015)

THRESHOLD PHARMACEUTICALS, Inc. FORM OF Warrant To Purchase Common Stock (Filed With SEC on March 3, 2015)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 3, 2015)

8,300,000 shares of Common Stock and Warrants to Purchase 8,300,000 Sharesof Common Stock Threshold Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 12, 2015)

THRESHOLDPHARMACEUTICALS, Inc. FORMOF WarrantTo Purchase Common Stock (Filed With SEC on February 12, 2015)

ThresholdPharmaceuticals, Inc. 2014Equity Incentive Plan Adoptedby the Board of Directors: March 20, 2014 Approvedby the Stockholders: May 16, 2014 (Filed With SEC on May 21, 2014)

ThresholdPharmaceuticals, Inc. Stock OptionGrant Notice (2014 Equity IncentivePlan) (Filed With SEC on May 21, 2014)

ThresholdPharmaceuticals, Inc. StockOption Grant Notice (2014Equity Incentive Plan) OptionGrant Non-EmployeeDirector Compensation Policy (Filed With SEC on May 21, 2014)

THRESHOLD PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Filed With SEC on May 1, 2014)

THRESHOLD PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED BY THE BOARD OF DIRECTORS:MARCH 20, 2014 (Filed With SEC on May 1, 2014)

AMENDMENT TO LICENSE ANDCO-DEVELOPMENT AGREEMENT (Filed With SEC on March 6, 2014)

LICENSE AND CO-DEVELOPMENT AGREEMENT (Filed With SEC on August 6, 2012)

LICENSE AND CO-DEVELOPMENT AGREEMENT BETWEEN THRESHOLD PHARMACEUTICALS AND MERCK KGAA LICENSE AND CO-DEVELOPMENT AGREEMENT (Filed With SEC on May 3, 2012)

THRESHOLD PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on April 12, 2012)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on April 12, 2012)

2004 AMENDED AND RESTATED EQUITY INCENTIVE PLAN OF THRESHOLD PHARMACEUTICALS, INC. (as amended on May 19, 2010 (the Amendment Date)) (Filed With SEC on March 15, 2012)

First Amendment to At Market Issuance Sales Agreement (Filed With SEC on January 20, 2012)

SUBLEASE (Filed With SEC on November 3, 2011)

14,313,081 Shares Warrants to Purchase 5,725,227 Shares THRESHOLD PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 11, 2011)

THRESHOLD PHARMACEUTICALS, INC. WARRANT (Filed With SEC on March 11, 2011)

THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on March 11, 2011)

THRESHOLD PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on October 29, 2010)

EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on March 8, 2010)

THRESHOLD PHARMACEUTICALS, INC. (Filed With SEC on September 30, 2009)

SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 30, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 30, 2009)

THRESHOLD PHARMACEUTICALS, INC. AMENDED AND RESTATED (Filed With SEC on November 21, 2008)

FORM OF WARRANT (Filed With SEC on July 14, 2008)

AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on July 14, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 14, 2008)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on November 26, 2007)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on November 7, 2007)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on October 25, 2007)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on April 4, 2007)

THRESHOLD PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Filed With SEC on March 15, 2007)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 15, 2007)

AGREEMENT AND GENERAL RELEASE (Filed With SEC on November 9, 2006)

THRESHOLD PHARMACEUTICALS, INC. and MELLON INVESTOR SERVICES LLC Rights Agent (Filed With SEC on August 9, 2006)

FORM OF RIGHTS CERTIFICATE (Filed With SEC on August 9, 2006)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 9, 2006)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 15, 2006)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED (Filed With SEC on March 28, 2006)

Shares (Filed With SEC on March 17, 2006)

TRIPLE NET SPACE LEASE (Filed With SEC on February 9, 2006)

[6,250,000] Shares (Filed With SEC on October 7, 2005)

THRESHOLD PHARMACEUTICALS, INC. FORM OF CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on September 16, 2005)

THRESHOLD PHARMACEUTICALS, INC. CONSULTING AGREEMENT AND AMENDMENT TO STOCK VESTING AGREEMENT (Filed With SEC on August 19, 2005)

2004 AMENDED AND RESTATED EQUITY INCENTIVEPLAN OF THRESHOLD PHARMACEUTICALS, INC. (Filed With SEC on May 24, 2005)

THRESHOLD PHARMACEUTICALS, INC. (Filed With SEC on February 3, 2005)

INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on January 28, 2005)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED (Filed With SEC on January 28, 2005)

Threshold Pharmaceuticals, Inc. (Filed With SEC on January 11, 2005)

2004 EMPLOYEE STOCKPURCHASE PLAN OF THRESHOLD PHARMACEUTICALS, INC. Table of Contents (Filed With SEC on January 11, 2005)

THRESHOLD PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on December 29, 2004)

THRESHOLD PHARMACEUTICALS, INC STOCK VESTING AGREEMENT (Filed With SEC on December 29, 2004)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED ANDFILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS... (Filed With SEC on December 6, 2004)

INDEMNIFICATION AGREEMENT (Filed With SEC on December 6, 2004)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED (Filed With SEC on December 6, 2004)

[LETTERHEAD OF THRESHOLD PHARMACEUTICALS, INC.] (Filed With SEC on December 6, 2004)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED (Filed With SEC on December 6, 2004)

WARRANT TO PURCHASE STOCK (Filed With SEC on April 9, 2004)

THRESHOLD PHARMACEUTICALS, INC. (Filed With SEC on April 9, 2004)

THRESHOLD PHARMACEUTICALS, INC. 2001 EQUITY INCENTIVE PLAN (Filed With SEC on April 9, 2004)

2004 EQUITY INCENTIVEPLAN OF THRESHOLD PHARMACEUTICALS, INC. (Filed With SEC on April 9, 2004)

SUBLEASE (Filed With SEC on April 9, 2004)

AMENDED AND RESTATED LEASE AGREEMENT BY AND BETWEEN HMS GATEWAY OFFICE L.P., a Delaware limited partnership (Filed With SEC on April 9, 2004)

*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED ANDFILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS... (Filed With SEC on April 9, 2004)

THRESHOLD PHARMACEUTICALS, INC. And SILICON VALLEYBANK TABLE OF CONTENTS (Filed With SEC on April 9, 2004)

Category

Industry

Companies

Contracts

Molecular Templates, Inc. Contracts & Agreements